RMD.AX - ResMed Inc.

ASX - ASX Delayed Price. Currency in AUD
Currency in AUD

Valuation Measures

Market Cap (intraday) 524.92B
Enterprise Value 326.53B
Trailing P/E 56.36
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.87
Price/Book (mrq)12.35
Enterprise Value/Revenue 310.51
Enterprise Value/EBITDA 634.97

Trading Information

Stock Price History

Beta (3Y Monthly) 0.75
52-Week Change 320.40%
S&P500 52-Week Change 37.29%
52 Week High 317.94
52 Week Low 312.65
50-Day Moving Average 317.15
200-Day Moving Average 315.38

Share Statistics

Avg Vol (3 month) 3993.94k
Avg Vol (10 day) 3972.88k
Shares Outstanding 51.43B
Float 1.42B
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 31.48
Trailing Annual Dividend Yield 38.41%
5 Year Average Dividend Yield 4N/A
Payout Ratio 411.33%
Dividend Date 3N/A
Ex-Dividend Date 4May 9, 2018
Last Split Factor (new per old) 21/2
Last Split Date 3Aug 12, 2010

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 17.65%
Operating Margin (ttm)24.50%

Management Effectiveness

Return on Assets (ttm)10.13%
Return on Equity (ttm)21.80%

Income Statement

Revenue (ttm)2.53B
Revenue Per Share (ttm)1.77
Quarterly Revenue Growth (yoy)11.90%
Gross Profit (ttm)1.36B
EBITDA 758.61M
Net Income Avi to Common (ttm)445.6M
Diluted EPS (ttm)0.31
Quarterly Earnings Growth (yoy)-4.30%

Balance Sheet

Total Cash (mrq)146.51M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)1.34B
Total Debt/Equity (mrq)66.08
Current Ratio (mrq)2.38
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)446.65M
Levered Free Cash Flow (ttm)419.04M